Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 7:57 PM View:  | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 19-Nov-24 | Private Sale (Planned) | 4,156 | $22.41 | $93,136.80 | (4%) 97.91K to 93.76K | |
| 20-Nov-24 8:00 PM View: | Kumar Neil Chief Executive Officer Director | Bridgebio Pharma, Inc. (BBIO) | 19-Nov-24 | Private Sale (Planned) | 27,389 | $22.41 | $613,826.00 | (< 1%) 6.93M to 6.91M | |
| 19-Nov-24 6:06 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-24 | Option Exercise | 25,799 | -- | -- | 30% 85.19K to 110.99K | |
| 19-Nov-24 6:15 PM View: | Kumar Neil Chief Executive Officer Director | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-24 | Payment of Exercise | 28,148 | $23.72 | $667,671.00 | (< 1%) 6.96M to 6.93M | |
| 19-Nov-24 6:15 PM View: | Kumar Neil Chief Executive Officer Director | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-24 | Option Exercise | 55,537 | -- | -- | < 1% 6.91M to 6.96M | |
| 19-Nov-24 6:06 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-24 | Payment of Exercise | 13,077 | $23.72 | $310,186.00 | (12%) 110.99K to 97.91K | |
| 19-Nov-24 6:13 PM View: | Trimarchi Thomas President and COO | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-24 | Payment of Exercise | 17,936 | $23.72 | $425,442.00 | (5%) 395.92K to 377.99K | |
| 17-Sep-24 6:44 PM View: | Kkr Genetic Disorder L.P. 10% Owner | Bridgebio Pharma, Inc. (BBIO) | 13-Sep-24 | Private Sale | 5,800,000 | $25.75 | $149,350,000.00 | (19%) 31.06M to 25.26M | |
| 20-Aug-24 6:27 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 19-Aug-24 | Planned Option Sale | 4,155 | $24.69 | $102,590.00 | (5%) 89.35K to 85.19K | |
| 20-Aug-24 6:31 PM View: | Kumar Neil Chief Executive Officer Director | Bridgebio Pharma, Inc. (BBIO) | 19-Aug-24 | Planned Option Sale | 27,389 | $24.69 | $676,256.00 | (< 1%) 6.93M to 6.91M | |
| 20-Aug-24 6:27 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-24 | Option Exercise | 25,797 | -- | -- | 34% 76.63K to 102.42K | |
| 20-Aug-24 6:31 PM View: | Kumar Neil Chief Executive Officer Director | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-24 | Payment of Exercise | 28,148 | $24.40 | $686,811.00 | (< 1%) 6.96M to 6.93M | |
| 20-Aug-24 6:24 PM View: | Trimarchi Thomas President and COO | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-24 | Payment of Exercise | 17,936 | $24.40 | $437,638.00 | (4%) 413.86K to 395.92K | |
| 20-Aug-24 6:31 PM View: | Kumar Neil Chief Executive Officer Director | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-24 | Option Exercise | 55,537 | -- | -- | < 1% 6.91M to 6.96M | |
| 20-Aug-24 6:27 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-24 | Payment of Exercise | 13,077 | $24.40 | $319,079.00 | (13%) 102.42K to 89.35K | |
| 08-Aug-24 4:39 PM View: | Trimarchi Thomas President and COO | Bridgebio Pharma, Inc. (BBIO) | 06-Aug-24 | Grant | 19,003 | -- | -- | 5% 394.86K to 413.86K | |
| 05-Jun-24 4:53 PM View: | Scott Randal W Director | Bridgebio Pharma, Inc. (BBIO) | 04-Jun-24 | Sale (Planned) | 1,500 | $31.30 | $46,950.00 | (14%) 10.5K to 9.0K | |
| 05-Jun-24 4:53 PM View: | Scott Randal W Director | Bridgebio Pharma, Inc. (BBIO) | 03-Jun-24 | Private Sale (Planned) | 1,000 | $28.84 | $28,842.50 | (9%) 11.5K to 10.5K | |
| 17-May-24 4:09 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-May-24 | Payment of Exercise | 13,943 | $31.04 | $432,791.00 | (15%) 90.42K to 76.47K | |
| 17-May-24 4:09 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-May-24 | Option Exercise | 27,507 | -- | -- | 44% 62.91K to 90.42K | |
| 17-May-24 4:11 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-May-24 | Payment of Exercise | 30,748 | $31.04 | $954,418.00 | (< 1%) 6.94M to 6.91M | |
| 17-May-24 4:11 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-May-24 | Option Exercise | 60,667 | -- | -- | < 1% 6.88M to 6.94M | |
| 05-Mar-24 4:00 PM View: | Scott Randal W Director | Bridgebio Pharma, Inc. (BBIO) | 01-Mar-24 | Private Sale (Planned) | 2,500 | $34.00 | $85,000.00 | (18%) 14.0K to 11.5K | |
| 21-Feb-24 4:03 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Payment of Exercise | 47,922 | $37.21 | $1,783,180.00 | (< 1%) 6.92M to 6.88M | |
| 21-Feb-24 4:04 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Option Exercise | 44,996 | -- | -- | 122% 36.83K to 81.83K | |
| 21-Feb-24 4:04 PM View: | Homcy Charles J Director | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Option Exercise | 3,760 | -- | -- | < 1% 1.23M to 1.23M | |
| 21-Feb-24 4:04 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Payment of Exercise | 18,919 | $37.21 | $703,976.00 | (23%) 81.83K to 62.91K | |
| 21-Feb-24 4:04 PM View: | Homcy Charles J Director | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Payment of Exercise | 1,509 | $37.21 | $56,149.90 | (< 1%) 1.23M to 1.23M | |
| 21-Feb-24 4:03 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Option Exercise | 102,249 | -- | -- | 1% 6.82M to 6.92M | |
| 20-Feb-24 4:03 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 15-Feb-24 | Option Exercise | 2,915 | $8.45 | $24,631.80 | 56% 5.2K to 8.11K | |
| 20-Feb-24 4:03 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 15-Feb-24 | Planned Option Sale | 2,915 | $37.75 | $110,041.00 | (36%) 8.11K to 5.2K | |
| 18-Jan-24 4:10 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 16-Jan-24 | Option Exercise | 2,915 | $8.45 | $24,631.80 | 165% 1.76K to 4.68K | |
| 18-Jan-24 4:10 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 16-Jan-24 | Planned Option Sale | 2,915 | $37.97 | $110,683.00 | (62%) 4.68K to 1.76K | |
| 28-Dec-23 4:00 PM View: | McCormick Frank Director | Bridgebio Pharma, Inc. (BBIO) | 26-Dec-23 | Private Sale (Planned) | 100,000 | $42.06 | $4,206,000.00 | (8%) 1.2M to 1.1M | |
| 20-Dec-23 4:00 PM View: | Scott Randal W Director | Bridgebio Pharma, Inc. (BBIO) | 18-Dec-23 | Private Sale (Planned) | 2,000 | $40.00 | $80,000.00 | (12%) 16.0K to 14.0K | |
| 19-Dec-23 4:00 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 15-Dec-23 | Planned Option Sale | 2,915 | $36.12 | $105,290.00 | (62%) 4.68K to 1.76K | |
| 19-Dec-23 4:00 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 15-Dec-23 | Option Exercise | 2,915 | $8.45 | $24,631.80 | 165% 1.76K to 4.68K | |
| 05-Dec-23 4:00 PM View: | Scott Randal W Director | Bridgebio Pharma, Inc. (BBIO) | 01-Dec-23 | Private Sale (Planned) | 2,500 | $29.40 | $73,500.00 | (14%) 18.5K to 16.0K | |
| 20-Nov-23 4:00 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 17-Nov-23 | Planned Option Sale | 51,552 | $29.10 | $1,500,040.00 | (< 1%) 6.87M to 6.82M | |
| 20-Nov-23 4:00 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 17-Nov-23 | Planned Option Sale | 22,685 | $29.10 | $660,059.00 | (38%) 59.4K to 36.71K | |
| 20-Nov-23 4:00 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Option Exercise | 44,996 | -- | -- | 123% 36.71K to 81.71K | |
| 20-Nov-23 4:00 PM View: | Homcy Charles J Director | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Option Exercise | 3,760 | -- | -- | < 1% 1.22M to 1.23M | |
| 20-Nov-23 4:00 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Payment of Exercise | 22,311 | $28.86 | $643,896.00 | (27%) 81.71K to 59.4K | |
| 20-Nov-23 4:00 PM View: | Homcy Charles J Director | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Payment of Exercise | 1,301 | $28.86 | $37,546.90 | (< 1%) 1.23M to 1.23M | |
| 20-Nov-23 4:00 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Option Exercise | 102,249 | -- | -- | 1% 6.82M to 6.92M | |
| 20-Nov-23 4:00 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Payment of Exercise | 50,697 | $28.86 | $1,463,120.00 | (< 1%) 6.92M to 6.87M | |
| 17-Nov-23 4:09 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 15-Nov-23 | Option Exercise | 2,915 | $8.45 | $24,631.80 | 165% 1.76K to 4.68K | |
| 17-Nov-23 4:09 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 15-Nov-23 | Planned Option Sale | 2,915 | $30.00 | $87,450.00 | (62%) 4.68K to 1.76K | |
| 07-Sep-23 4:00 PM View: | Scott Randal W Director | Bridgebio Pharma, Inc. (BBIO) | 05-Sep-23 | Private Sale (Planned) | 2,500 | $30.00 | $75,000.00 | (12%) 21.0K to 18.5K | |
| 18-Aug-23 4:00 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 17-Aug-23 | Planned Option Sale | 51,552 | $28.59 | $1,473,780.00 | (< 1%) 6.87M to 6.82M |
